The Registry of Toxic Effects of Chemical Substances
Acetic acid, dichloro - |
UPDATE: February 2005 | MW: 128.94 | MF: C2H2Cl2O2 |
SYNONYMS:
|
|
|
SKIN AND EYE IRRITATION DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
skin | rabbit
2 mg/24 hour
|
severe
|
85JCAE -,570,1986
|
|
MUTATION DATA AND REFERENCES:
SYSTEM TEST
|
ROUTE/ | ORGANISM/ TISSUE
DOSE
|
REFERENCE
|
cytogenetic analysis
|
mouse
lymphocyte
|
600 mg/L
|
MUREAV 413,265,1998
|
DNA damage
|
oral | mouse
645 mg/kg
|
EMMUEG 20,277,1992
|
DNA damage
|
oral | mouse
35,840 mg/kg/8 week- intermittent
|
TOSCF2 77,243,2004
|
micronucleus test
|
oral | mouse
1,800 mg/kg/9 day- continuous
|
EMMUEG 27,1,1996
|
mutation in mammalian somatic cells
|
mouse
lymphocyte
|
400 mg/L
|
MUREAV 413,265,1998
|
|
REPRODUCTIVE EFFECTS DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
oral | rat
lowest published toxic dose: 9 gm/kg (6-15 day pregnant)
|
Reproductive: Effects on fertility: Post- implantation mortality (e.g., dead and/or resorbed implants per total number of implants) | Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus)
TJADAB 46,217,1992
|
oral | rat
lowest published toxic dose: 24 gm/kg (6-15 day pregnant)
|
Reproductive: Effects on newborn: Sex ratio
|
TJADAB 46,217,1992
|
oral | rat
lowest published toxic dose: 4 gm/kg (6-15 day pregnant)
|
Reproductive: Specific developmental abnormalities: Cardiovascular (circulatory) system
|
TJADAB 46,217,1992
|
oral | rat
lowest published toxic dose: 14 gm/kg (6-15 day pregnant)
|
Reproductive: Specific developmental abnormalities: Urogenital system
|
TJADAB 46,217,1992
|
|
TUMORIGENIC DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
oral | mouse
lowest published toxic dose: 427 gm/kg/61 week- continuous
|
Tumorigenic: Carcinogenic by RTECS criteria | Liver: Tumors
TXAPA9 90,183,1987
|
oral | mouse
toxic dose : 58,800 mg/kg/2 year- continuous
|
Tumorigenic: Carcinogenic by RTECS criteria | Liver: Tumors
JTEHF8 58,485,1999
|
oral | mouse
lowest published toxic dose: 166 gm/kg/46 week- continuous
|
Tumorigenic: Carcinogenic by RTECS criteria | Liver: Tumors Tumorigenic: Facilitates action of known carcinogens
CALEDQ 158,185,2000
|
oral | mouse
lowest published toxic dose: 60.9 gm/kg/87 week- continuous
|
Tumorigenic: Equivocal tumorigenic agent by RTECS criteria | Liver: Tumors
TOSCF2 59,178,2001
|
oral | mouse
lowest published toxic dose: 145.6 gm/kg/52 week- intermittent
|
Tumorigenic: Carcinogenic by RTECS criteria | Liver: Tumors Tumorigenic: Increased incidence of tumors in susceptible strains
TXAPA9 182,55,2002
|
oral | mouse
lowest published toxic dose: 197,120 mg/kg/44 week- intermittent
|
Tumorigenic: Carcinogenic by RTECS criteria | Liver: Tumors Tumorigenic: Increased incidence of tumors in susceptible strains
TOSCF2 77,243,2004
|
oral | rat
lowest published toxic dose: 100 gm/kg/2 year- continuous
|
Tumorigenic: Carcinogenic by RTECS criteria | Liver: Tumors
TXCYAC 114,207,1996
|
oral | rat
lowest published toxic dose: 101 gm/kg/60 week- intermittent
|
Tumorigenic: Neoplastic by RTECS criteria | Liver: Tumors
CALEDQ 92,67,1995
|
|
ACUTE TOXICITY DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
oral | rat
lethal dose (50 percent kill): 2,820 mg/kg
|
N/R
|
AMIHBC 4,119,1951
|
skin | rabbit
lethal dose (50 percent kill): 510 µL/kg
|
N/R
|
AMIHBC 4,119,1951
|
|
OTHER MULTIPLE DOSE DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
intraperitoneal | rat
lowest published toxic dose: 774 mg/kg/5 day- intermittent
|
Kidney, Ureter, and Bladder: Changes in tubules (including acute renal failure, acute tubular necrosis)
|
TOSCF2 70,261,2002
|
intraperitoneal | rat
lowest published toxic dose: 232 mg/kg/3 day- intermittent
|
Kidney, Ureter, and Bladder: Other changes in urine composition
|
TOSCF2 74,192,2003
|
oral | mouse
lowest published toxic dose: 7,100 mg/kg/10 week- continuous
|
Liver: Other changes | Liver: Changes in liver weight Biochemical: Effect on specific coenzyme: CoA
TXCYAC 110,103,1996
|
oral | mouse
lowest published toxic dose: 5.6 gm/kg/2 week- continuous
|
Endocrine: Diabetes mellitus
|
TOSCF2 59,178,2001
|
oral | mouse
lowest published toxic dose: 1.4 gm/kg/2 week- continuous
|
Liver: Other changes
|
TOSCF2 59,178,2001
|
oral | mouse
lowest published toxic dose: 7 gm/kg/10 week- continuous
|
Liver: Other changes | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Phosphokinase
TOSCF2 59,178,2001
|
oral | mouse
lowest published toxic dose: 1.4 gm/kg/2 week- intermittent
|
Liver: Other changes | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Isomerases
TXCYAC 173,229,2002
|
oral | mouse
lowest published toxic dose: 5,600 mg/kg/100 week- continuous
|
Liver: Other changes | Liver: Tumors Tumorigenic: Increased incidence of tumors in susceptible strains
EVHPAZ 111,53,2003
|
oral | mouse
lowest published toxic dose: 30,576 mg/kg/52 week- continuous
|
Liver: Other changes
|
EVHPAZ 111,53,2003
|
oral | mouse
lowest published toxic dose: 30,576 mg/kg/26 week- continuous
|
Liver: Hepatitis (hepatocellular necrosis), diffuse
|
EVHPAZ 111,53,2003
|
oral | mouse
lowest published toxic dose: 57,330 mg/kg/26 week- continuous
|
Liver: Hepatitis (hepatocellular necrosis), diffuse | Liver: Other changes Liver: Tumors
EVHPAZ 111,53,2003
|
oral | mouse
lowest published toxic dose: 115 gm/kg/52 week- continuous
|
Liver: Other changes | Liver: Tumors Tumorigenic: Increased incidence of tumors in susceptible strains
EVHPAZ 111,53,2003
|
oral | mouse
lowest published toxic dose: 300 gm/kg/100 week- continuous
|
Liver: Hepatitis (hepatocellular necrosis), diffuse | Liver: Tumors Tumorigenic: Increased incidence of tumors in susceptible strains
EVHPAZ 111,53,2003
|
oral | rat
lowest published toxic dose: 3,195 mg/kg/90 day- continuous
|
Kidney, Ureter, and Bladder: Changes in bladder weight | Nutritional and Gross Metabolic: Weight loss or decreased weight gain Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Phosphatases
TXCYAC 64,71,1990
|
oral | rat
lowest published toxic dose: 3,588 mg/kg/5 week- intermittent
|
Gastrointestinal: Other changes | Nutritional and Gross Metabolic: Weight loss or decreased weight gain Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Other enzymes
TOSCF2 56,282,2000
|
|
REVIEWS:
ORGANIZATION
|
STANDARD
|
|
REFERENCE
International Agency for Research on Cancer (IARC) Cancer Review
|
Animal Limited Evidence
|
IMEMDT 63,271,1995
|
International Agency for Research on Cancer (IARC) Cancer Review
|
Human Inadequate Evidence
|
IMEMDT 63,271,1995
|
International Agency for Research on Cancer (IARC) Cancer Review
|
Group 3
|
IMEMDT 63,271,1995
|
TOXICOLOGY REVIEW
|
|
TOLED5 135,167,2002
|
TOXICOLOGY REVIEW
|
|
MUREAV 5641792004
|
|
STANDARDS AND REGULATIONS:
ORGANIZATION
|
STANDARD
|
|
REFERENCE
Occupational Exposure Limit - RUSSIA
|
short term exposure limit 4 mg/m3, JAN1993
|
|
NIOSH DOCUMENTATION AND SURVEILLANCE:
ORGANIZATION
|
STANDARD or SURVEY
|
|
REFERENCE
National Occupational Hazard Survey 1974
|
National Occupational Hazard Survey 1974: Hazard Code: 84531; | Number of Industries 3; Total Number of Facilities 44; Number of Occupations 5; Total Number of Employees Exposed 164
National Occupational Exposure Survey 1983
|
National Occupational Exposure Survey 1983: Hazard Code: 84531; |
Number of Industries 1; Total Number of Facilities 39; Number of Occupations 2; Total Number of Employees Exposed 1,592; Total Number of Female Employees Exposed 579 |
STATUS IN FEDERAL AGENCIES:
ORGANIZATION
|
|
REFERENCE
EPA TSCA Section 8(b) CHEMICAL INVENTORY
|
Used as starting material for the production of glyoxylic, dialkyloxy acids and sulfonamides
|
EPA TSCA Section 8(d) unpublished health/safety studies
|
On EPA IRIS database
|
EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001
|
NTP Carcinogenesis studies; on test (prechronic studies), October 2000
|
|
REFERENCES:
CODEN
|
|
REFERENCE
85JCAE
|
"Prehled Prumyslove Toxikologie; Organicke Latky," Marhold, J., Prague, Czechoslovakia,
Avicenum, 1986
|
AMIHBC
|
AMA Archives of Industrial Hygiene and Occupational Medicine. (Chicago, IL) V.2-10, 1950-54.
For publisher information, see AEHLAU.
|
CALEDQ
|
Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick,
Ireland) V.1- 1975-
|
EMMUEG
|
Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY
10003) V.10- 1987-
|
EVHPAZ
|
EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents,
Washington, DC 20402) No.1- 1972-
|
IMEMDT
|
IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications
Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972-
|
JTEHF8
|
Journal of Toxicology and Environmental Health, Part A. (Taylor & Francis, 47 Runway Rd.,
Suite G, Levittown, PA 19057) V.53- 1998-
|
MUREAV
|
Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1-
1964-
|
TJADAB
|
Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E.
11th St., New York, NY 10003) V.1- 1968-
|
TOLED5
|
Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands)
V.1- 1977-
|
TOSCF2
|
Toxicological Sciences (Oxford University Press, 6277 Sea Harbor Drive, Orlando, FL 32887 )
V. 41, Jan. 1998-
|
TXAPA9
|
Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802)
V.1- 1959-
|
TXCYAC
|
Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973-
|
|